对酒精和博协会的企业赞助进行映射:澳大利亚的一项试点研究
Cara Platts1, Jennifer Lacy-Nichols1
1Centre for Health Equity, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
Addiction (Abingdon, England)
|February 5, 2025
概括
许多澳大利亚酒精和博行业协会对其成员和合作伙伴缺乏透明度. 这些多元化的企业实体很少披露他们对这些行业集团的支持.
科学领域:
- 公共卫生政策 公共卫生政策
- 产业影响分析 产业影响分析
- 公司透明度 企业透明度
背景情况:
- 酒精和博行业积极反对公共卫生政策.
- 行业协会是推动这些行业利益的关键参与者.
- 关于这些协会的会员和伙伴关系的研究有限.
研究的目的:
- 绘制澳大利亚酒精和博协会的地图.
- 识别他们的成员,合作伙伴和相互联系.
- 分析这些关系的透明度.
主要方法:
- 对行业协会进行系统的搜索.
- 成员/合伙人的识别和分类.
- 关系的映射 (雨,共同定位,联合) 和披露分析.
主要成果:
- 确定了126个协会和1486个公司/组织.
- 只有59.5%的协会披露了成员/合伙人.
- 发现了广泛的网络,透明度低 (13.8%披露).
结论:
- 许多澳大利亚的酒精和博协会在披露成员和合作伙伴方面缺乏透明度.
- 企业合作伙伴多样化,很少披露他们的支持.
- 这些协会提供的资金信息有限.
关键词:
酒精行业 酒精行业 酒精行业健康的商业决定因素博行业 博行业 博行业网络 网络 网络 网络 网络 网络合作伙伴关系 合作伙伴关系 合作伙伴关系峰值的身体的身体.赞助 赞助 赞助 赞助 赞助第三方集团第三方集团的第三方集团.透明度 透明度 透明度更多相关视频
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
7.9K
05:40The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
Published on: April 28, 2022
3.0K
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
138
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
138
Protection of Alcohols
7.2K
This lesson delves into the concept of protection and deprotection of a functional group fundamental to synthetic organic chemistry. These phenomena are explained in the context of aliphatic and aromatic alcohols.
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
7.2K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Drug Dependence
968
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
968
Drug-Receptor Bonds
2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.7K
